NewsSan Diego Business JournalAugust 3, 2026San Diego
Rapalogix Health develops skin aging modulation technology
Rapalogix Health is developing a skincare product designed to modulate biological mechanisms of skin aging rather than focusing solely on visible symptoms. The company aims to address the underlying causes of cellular damage in the skin.
Read the full story at San Diego Business JournalWhy It Matters
This development represents a shift in the skincare industry toward biological cellular modulation, potentially impacting the $200 billion global skincare market.
Key Facts
- The global skincare market is projected to generate $200 billion in revenue this year.
- Most current skincare products target visible signs of aging.
- Rapalogix Health is focusing on modulating biological mechanisms that cause skin aging.
- The company's approach involves targeting older or damaged skin cells.